Company Ticker News March 14, 2022Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results 0 0 Share
Company Ticker News February 23, 2022Verve Therapeutics to Present at the Cowen 42nd Annual Healthcare Conference 0 0 Share
Press Release January 10, 2022Verve Therapeutics Announces 2022 Anticipated Milestones and Preclinical Data on Potential Additional Dosing Regimens for its Novel Base Editing Programs 0 0 Share
Company Ticker News January 3, 2022Verve Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference 0 0 Share
Company Ticker News November 29, 2021Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer 0 0 Share
Company Ticker News November 10, 2021Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2021 Financial Results 0 0 Share
Press Release November 9, 2021Verve Therapeutics Reports Preclinical Data Demonstrating Potent Editing of ANGPTL3 Gene Using Proprietary GalNAc-LNP Delivery Technology in Non-Human Primates 0 0 Share
Press Release October 21, 2021Verve Therapeutics to Participate in the Jefferies Gene Therapy/Editing Summit 0 0 Share
Press Release September 27, 2021Verve Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference 0 0 Share
